Dermtech, inc. (CNAC)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16
Cash flows from operating activities:
Net loss

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income

-

-

-

361

944

1,339

1,087

1,331

856

466

214

-31

-0

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount and issuance costs

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Inventory

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued compensation

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities and deferred revenue

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Interest earned on marketable securities held in Trust Account

-

-

-

2,284

2,863

2,627

2,153

1,842

1,208

726

365

14

0

0

0

0

Unrealized (gain) loss on securities held in Trust Account

-

-

-

110

59

-42

-53

-69

-45

-35

-23

-23

0

0

0

0

Reduction of deferred underwriting fee

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-21

-42

-25

-20

-31

93

67

97

98

0

0

0

0

Accounts payable and accrued expenses

-

-

-

2,323

1,491

685

618

44

26

0

0

0

-

-

-

-

Net cash used in operating activities

-22,482

-17,791

-11,924

-3,097

-3,135

-534

-373

-366

-373

0

0

0

-

-

-

-

Cash flows from investing activities:
Purchases of property and equipment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Investment of cash in Trust Account

-

-

-

-

-

-

-

-

145,187

145,187

145,187

145,187

0

0

0

0

Net cash used in investing activities

0

-

-

-

0

-

-

-

-145,187

0

0

0

-

-

-

-

Cash flows from financing activities:
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of Units, net of underwriting discounts paid

-

-

-

-

-

-

-

-

140,875

140,875

140,875

140,875

0

0

0

0

Proceeds from sale of Private Units

-

-

-

-

-

-

-

-

5,612

5,612

5,612

5,612

0

0

0

0

Advances received from related party

-

-

-

35

25

24

0

21

162

219

219

197

56

0

0

0

Repayment of advances from related party

-

-

-

-

-

-

-

-

319

319

319

318

14

0

0

0

Payments of issuance costs in connection with Form S-1 registration statement

0

-

-

-

-

-

-

-

344

376

378

378

35

0

0

0

Proceeds from exercise of common stock warrants

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

225,656

28,622

28,472

-136,879

-136,889

24

0

6

145,985

0

0

0

-

-

-

-

Net increase/(decrease) in cash and cash equivalents

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow information:
Purchases of property and equipment recorded in accounts payable

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Non-cash investing and financing activities
Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net change in cash

-

-

-

-370

-419

-509

-373

-359

424

554

607

730

8

0

0

0

Offering costs charged to additional paid in capital

-

-

-

-

-

-

-

-

301

301

301

301

0

0

0

0

Deferred underwriting fee payable

-

-

-

-

-

-

-

-

5,031

5,031

5,031

5,031

0

0

0

0

Initial classification of ordinary shares subject to possible redemption

-

-

-

-

-

-

-

-

135,963

135,963

135,963

135,963

0

0

0

0

Change in value of ordinary shares subject to possible redemption

-

-

-

639

944

1,339

1,087

1,331

856

466

215

-31

0

0

0

0

Private placement
Proceeds from issuance of common stock in connection with private placement offering, net

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B-1 Convertible Preferred Stock
Proceeds from issuance of Convertible Preferred Stock, net

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B-2 Convertible Preferred Stock
Proceeds from issuance of Convertible Preferred Stock, net

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Affiliated Entity [Member]
Accounts payable paid by related party under the form of promissory notes

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-